<p><b>Copyright information:</b></p><p>Taken from "Therapy for pneumonitis and sialadenitis by accumulation of CCR2-expressing CD4CD25regulatory T cells in MRL/lpr mice"</p><p>http://arthritis-research.com/content/9/1/R15</p><p>Arthritis Research & Therapy 2007;9(1):R15-R15.</p><p>Published online 7 Feb 2007</p><p>PMCID:PMC1860074.</p><p></p> Representative photographs are shown. Treg and CCR2-Treg cells were transferred via retro-orbital injection in 12-week-old MRL/lpr mice. One hundred thousand or 5 × 10cells were injected into mice twice every 2 weeks, and the pathological changes were evaluated 3 weeks after the last injection (that is, when the mice were 17 weeks old). Non-treated 17-week-old MRL/lpr mice were used as control. CCR2-Treg cell, CD4CD25Foxp3CCR2-transfected T cell; HE, hematoxylin and eosin; MRL/lpr, MRL/MpJ-/; Treg cell, CD4CD25Foxp3T cell
